Royal London UK FTSE4Good Tracker TrustRegister to Unlock Ratings |
Performance History | 30/09/2024 |
Growth of 1,000 (GBP) | Advanced Graph |
Fund | -10.7 | 16.2 | 1.2 | 7.8 | 10.6 | |
+/-Cat | -1.6 | -1.7 | 3.2 | -0.4 | 1.2 | |
+/-B’mrk | - | - | - | 0.2 | 0.7 | |
Category: UK Large-Cap Equity | ||||||
Category Benchmark: Morningstar UK All Cap TME ... |
Key Stats | ||
NAV 10/10/2024 | GBX 312.00 | |
Day Change | 0.22% | |
Morningstar Category™ | UK Large-Cap Equity | |
IA (formerly IMA) Sector | UK All Companies | |
ISIN | GB00B05Q3G94 | |
Fund Size (Mil) 10/10/2024 | GBP 43.94 | |
Share Class Size (Mil) 10/10/2024 | GBP 43.94 | |
Max Initial Charge | - | |
Ongoing Charge 15/02/2024 | 0.25% |
Investment Objective: Royal London UK FTSE4Good Tracker Trust |
The Scheme’s investment objective is to achieve capital growth over the medium-to-long term, which should be considered as a period of 5-7 years, principally by matching the performance before the deduction of charges of the FTSE4Good UK GBP Index (the “Index”) of shares. At least 90% of the Scheme will be invested in the shares of companies that belong to the Index. |
Returns | |||||||||||||
|
Management | ||
Manager Name Start Date | ||
Nils Jungbacke 04/01/2018 | ||
Michael Sprot 18/09/2003 | ||
Inception Date 18/09/2003 |
Advertisement |
Category Benchmark | |
Fund Benchmark | Morningstar Benchmark |
FTSE4Good UK TR GBP | Morningstar UK All Cap TME NR GBP |
Target Market | ||||||||||||||||||||
|
Portfolio Profile for Royal London UK FTSE4Good Tracker Trust | 31/08/2024 |
|
|
Top 5 Holdings | Sector | % |
AstraZeneca PLC | Healthcare | 10.28 |
Shell PLC | Energy | 8.92 |
HSBC Holdings PLC | Financial Services | 6.48 |
Unilever PLC | Consumer Defensive | 6.26 |
GSK PLC | Healthcare | 3.42 |
Increase Decrease New since last portfolio | ||
Royal London UK FTSE4Good Tracker Trust |